Confirmation of double-peaked time distribution of mortality among Asian breast cancer patients in a population-based study

Division of Clinical Trials and Epidemiological Sciences, National Cancer Centre, Singapore.
Breast cancer research: BCR (Impact Factor: 5.49). 02/2007; 9(2):R21. DOI: 10.1186/bcr1658
Source: PubMed


Double-peaked time distributions of the mortality hazard function have been reported for breast cancer patients from Western populations treated with mastectomy alone. These are thought to reflect accelerated tumour growth at micrometastatic sites mediated by angiogenesis after primary tumour removal as well as tumor dormancy. Similar data are not available for Asian populations. We sought to investigate whether differences exist in the pattern of mortality hazard function between Western breast cancer patients and their Asian counterparts in Singapore, which may suggest underlying differences in tumor biology between the two populations.
We performed a retrospective cohort study of female unilateral breast cancer patients diagnosed in Singapore between October 1994 and June 1999. Data regarding patient demographics, tumour characteristics and death were available. Overall survival curves were calculated using the Kaplan-Meier method. The hazard rate was calculated as the conditional probability of dying in a time interval, given that the patient was alive at the beginning of the interval. The life table method was used to calculate the yearly hazard rates.
In the 2,105 women identified, 956 patients (45.4%) had mastectomy alone. Demographic characteristics were as follows: 86.5% were Chinese, 45.2% were postmenopausal, 38.9% were hormone receptor positive, 54.6% were node negative and 44.1% had high histological grade. We observed a double-peaked mortality hazard pattern, with a first peak in mortality achieving its maximum between years 2 and 4 after mastectomy, and a second large peak in mortality during year 9. Analyses by subgroups revealed a similar pattern regardless of T stage, or node or menopausal status. This pattern was also noted in high-grade tumors but not in those that were well to moderately differentiated. The double-peaked pattern observed in Singaporean women was quantitatively and qualitatively similar to those reported in Western series.
Our study confirms the existence of a double-peaked process in Asian patients, and it gives further support to the tumour dormancy hypothesis after mastectomy.

Download full-text


Available from: PubMed Central · License: CC BY
  • Source
    • "In addition to immunosuppression [11] and hormone deprival [14], it has been suggested that wound healing following the primary surgery might be one such synchronizing signal, by turning on the angiogenic switch in dormant micrometastases and thereby activating angiogenesis [16–18]. The frequently observed peak in the hazard ratio of relapse around 18 months, independent of primary tumor stage [20, 25, 43], has been attributed to the systemic response to primary surgery of breast tumors [44]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: A significant variation in the metastatic pattern among breast cancer patients exists. Clinical observations suggest that these differences are related to time to recurrence (TTR), thus suggesting a common systemic growth signal at the time of surgery. Our goal was to identify a marker for synchronized growth of micrometastases. To quantify the metastatic pattern at first relapse, 180 patients with metastatic breast cancer were studied. Standard deviation (SD) of lesions size and lesion number was calculated and served as a marker for variation. Patients with low SD (multiple/similar sized lesions) were assumed to have synchronized growth, whereas patients with high SD were assumed to have unsynchronized growth. Patients were grouped according to TTR; early (< 3 years-) or late (> 3 years- after surgery). In patients not receiving systemic adjuvant treatment, median SD was significantly lower in the early group (2.5 mm) compared with 6.4 mm in the late group (p = 0.005). In node negative patients, median SD was significantly lower in the early group (3.0 mm) when compared with the late group (5.7 mm, p = 0.02). An additional drop in SD was observed immediately after end of adjuvant endocrine therapy. Our results identify SD as a marker of synchronized metastatic growth in breast cancer. A metastatic phenotype characterized by multiple similar sized metastases, suggesting synchronized onset of growth of micrometastases was predominantly found in patients recurring early after surgery and was counteracted by adjuvant treatment. Systemic growth signals caused by surgery might be antagonized during the time window following surgery.
    Full-text · Article · Jul 2014 · Breast Cancer Research and Treatment
  • Source
    • "In the seminal Milan series of 1173 patients with early stage breast cancer, recurrence occurred at a sharp peak at 18 months after diagnosis and initial treatment, with a nadir at 50 months, and a second, more broad peak at 60 months. Similar bimodal recurrence patterns in breast cancer patients have been independently reported by several other groups [8-10]. In looking at factors that are potentially related to recurrence, Demicheli and Retsky et al. have suggested that surgical resection of the primary tumor is responsible for the first peak by providing appropriate stimuli (e.g., angiogenic factors) to promote escape from tumor dormancy at distant metastatic sites [11,12]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: According to the concept of tumor dormancy, tumor cells may exist as single cells or microscopic clusters of cells that are clinically undetectable, but remain viable and have the potential for malignant outgrowth. At metastatic sites, escape from tumor dormancy under more favorable local microenvironmental conditions or through other, yet undefined stimuli, may account for distant recurrence after supposed "cure" following surgical treatment of the primary tumor. The vast majority of evidence to date in support of the concept of tumor dormancy originates from animal studies; however, extensive epidemiologic data from breast cancer strongly suggests that this process does occur in human disease. In this review, we aim to demonstrate that metastatic tumor dormancy does exist in cutaneous melanoma based on evidence from mouse models and clinical observations of late recurrence and occult transmission by organ transplantation. Experimental data underscores the critical role of impaired angiogenesis and immune regulation as major mechanisms for maintenance of tumor dormancy. Finally, we examine evidence for the role of surgery in promoting escape from tumor dormancy at metastatic sites in cutaneous melanoma.
    Full-text · Article · Dec 2011 · Cancers
  • Source
    • "These theories were proposed to explain a bimodal relapse pattern which was initially reported in two databases and has now been identified in 13 independent databases [6–17]. This bimodal pattern strongly implies that there is more than one mode of relapse. "
    [Show abstract] [Hide abstract]
    ABSTRACT: A small international group has recently challenged fundamental concepts in breast cancer. As a guiding principle in therapy, it has long been assumed that breast cancer growth is continuous. However, this group suggests tumor growth commonly includes extended periods of quasi-stable dormancy. Furthermore, surgery to remove the primary tumor often awakens distant dormant micrometastases. Accordingly, over half of all relapses in breast cancer are accelerated in this manner. This paper describes how a numerical algorithm was used to come to these conclusions. Based on these findings, a dormancy preservation therapy is proposed.
    Full-text · Article · Feb 2009 · International Journal of Environmental Research and Public Health
Show more